Present and future of breast cancer anti-Her-2-therapy

The paper describes a new class of molecular targeted antitumor agents against the molecules involved in carcinogenesis. It considers the basic drugs of this class and their combinations and evaluates the efficiency of their use in therapy for breast cancer.

Bibliographic Details
Main Author: V. P. Letyagin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/160